|
|
SPOT ON
|
|
Cardiotoxicity of cox-2-inhibitors and conventional NSAID: naproxen new standard
|
|
|
REVIEW
|
|
Treatment of age-related macular degeneration (I)
|
|
|
THERAPY FORM A CRITICAL VIEWPOINT
|
|
Once again: duration of therapy with clopidogrel (ISCOVER, PLAVIX) after drug-eluting stents
|
|
|
IN BRIEF
|
|
Australia: price reduction for vaccine against human papilloma virus (HPV) GARDASIL
Olanzapine (ZYPREXA) and Eli Lilly: suppression of risk data
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Management of opiod-patches (e.g. Fentanyl (DUROGESIC)) fault-prone
|
|
|
SIDE EFFECTS
|
|
US: market limitation of indications for telithromycine (KETEK) recommended
|
|